Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-3.70%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-3.70%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
26.41%
40%
—
—
Never
—
5 Years
Score—
Net Growth26.41%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Explore the 2021 public Archive ranking →
Where Alzamend Neuro Inc has ranked, year by year
Measure
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. ALZN does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-06 | $ 1.37 | — |
1 Year2025-10-06 | $ 2.56 | -46.48% |
5 Years2021-10-06 | $ 3.54K | -99.96% |
All Time2021-06-15 | $ 18.23K | -99.99% |
| Period | Last Price2026-10-06 | 1 Year2025-10-06 | 5 Years2021-10-06 | All Time2021-06-15 |
|---|---|---|---|---|
| Price | $ 1.37 | $ 2.56 | $ 3.54K | $ 18.23K |
| Return | — | -46.48% | -99.96% | -99.99% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 0.00 | -$ 9M | $ 7M |
| 2026 | $ 0.00 | -$ 8M | $ 710.69K |
| 2025 | $ 0.00 | -$ 4M | $ 3M |
| 2024 | $ 0.00 | -$ 9M | $ 376.05K |
| 2023 | $ 0.00 | -$ 14M | $ 5M |
| 2022 | $ 0.00 | -$ 12M | $ 14M |
Alzamend Neuro Inc fundamental performance
Across Alzamend Neuro Inc's full reported history, from 2022 to 2026, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 12M to -$ 8M. Revenue increased in 0% of the years measured; net income in 40%.
Membership
Explore ALZN with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,122 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
